[1]
Desai, S. 2021. Cysteamine: Clinical efficacy, safety and tolerability versus best-in-class treatments for melasma . SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s88. DOI:https://doi.org/10.25251/skin.5.supp.88.